SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies - Quaterly Results

21 Jul 2026 Evaluate
A decent increase of about 30.39% in the sales to Rs. 1788.00 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 1371.30 millions during the year-ago period.The Total revenue for the quarter ended June 2026 of  Rs. 255.30  millions  grew by 118.39% from Rs. 116.90 millions.Operating Profit saw a handsome growth to 391.10 millions from 206.50 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1788.00 1371.30 30.39 1788.00 1371.30 30.39 7687.30 6444.70 19.28
Other Income 25.50 27.20 -6.25 25.50 27.20 -6.25 114.60 157.70 -27.33
PBIDT 391.10 206.50 89.39 391.10 206.50 89.39 1553.70 907.70 71.17
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 391.10 206.50 89.39 391.10 206.50 89.39 1553.70 1006.80 54.32
Depreciation 65.10 59.50 9.41 65.10 59.50 9.41 246.90 216.20 14.20
PBT 326.00 147.00 121.77 326.00 147.00 121.77 1306.80 790.60 65.29
TAX 70.70 30.10 134.88 70.70 30.10 134.88 313.70 265.10 18.33
Deferred Tax -11.30 -6.90 63.77 -11.30 -6.90 63.77 -15.20 46.50 -132.69
PAT 255.30 116.90 118.39 255.30 116.90 118.39 993.10 525.50 88.98
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 21.87 15.06 45.26 21.87 15.06 45.26 20.21 14.08 43.50

Venus Remedies Share Price

1580.00 37.85 (2.45%)
05-Aug-2026 12:31 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1941.15
Dr. Reddys Labs. 1172.40
Cipla 1452.15
Lupin 2379.50
Zydus Lifesciences 1110.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: